St. Joseph Aspirin Is First J&J/McNeil Divestiture From 2010 OTC Recalls
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson unloads St. Joseph Aspirin, an OTC brand that suffered a significant dip in sales following a 2010 recall due to contaminated packaging.